These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 7528599)
1. Binding, internalization and excretion of TGF alpha-dextran associated radioactivity in cultured human glioma cells. Lövqvist A; Lindström A; Carlsson J Cancer Biother; 1993; 8(4):345-56. PubMed ID: 7528599 [TBL] [Abstract][Full Text] [Related]
2. Internalization and excretion of epidermal growth factor-dextran-associated radioactivity in cultured human squamous-carcinoma cells. Olsson P; Lindström A; Carlsson J Int J Cancer; 1994 Feb; 56(4):529-37. PubMed ID: 7509322 [TBL] [Abstract][Full Text] [Related]
3. Penetration and binding of epidermal growth factor-dextran conjugates in spheroids of human glioma origin. Lindström A; Carlsson J Cancer Biother; 1993; 8(2):145-58. PubMed ID: 7528598 [TBL] [Abstract][Full Text] [Related]
4. Binding of epidermal growth factor-dextran conjugates to cultured glioma cells. Andersson A; Holmberg A; Carlsson J; Carlsson J; Pontén J; Westermark B Int J Cancer; 1991 Feb; 47(3):439-44. PubMed ID: 1704355 [TBL] [Abstract][Full Text] [Related]
5. Binding, internalization and degradation of EGF-dextran conjugates in two human bladder-cancer cell lines. Sjöström A; Bue P; Malmström PU; Nilsson S; Carlsson J Int J Cancer; 1997 Feb; 70(4):383-9. PubMed ID: 9033643 [TBL] [Abstract][Full Text] [Related]
6. Strategy for boron neutron capture therapy against tumor cells with over-expression of the epidermal growth factor-receptor. Carlsson J; Gedda L; Grönvik C; Hartman T; Lindström A; Lindström P; Lundqvist H; Lövqvist A; Malmqvist J; Olsson P Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):105-15. PubMed ID: 7521866 [TBL] [Abstract][Full Text] [Related]
7. Development and in vitro studies of epidermal growth factor-dextran conjugates for boron neutron capture therapy. Gedda L; Olsson P; Pontén J; Carlsson J Bioconjug Chem; 1996; 7(5):584-91. PubMed ID: 8889021 [TBL] [Abstract][Full Text] [Related]
8. Cellular retention of radioactivity and increased radiation dose. Model experiments with EGF-dextran. Sundberg AL; Blomquist E; Carlsson J; Steffen AC; Gedda L Nucl Med Biol; 2003 Apr; 30(3):303-15. PubMed ID: 12745022 [TBL] [Abstract][Full Text] [Related]
10. Effects of EGF-dextran-tyrosine-131I conjugates on the clonogenic survival of cultured glioma cells. Andersson A; Capala J; Carlsson J J Neurooncol; 1992 Nov; 14(3):213-23. PubMed ID: 1281225 [TBL] [Abstract][Full Text] [Related]
11. Binding of 125I after administration of 125I-EGF-dextran, 125I-EGF or 125I to human bladder cancer spheroids. Sjöström A; Bue P; Malmstrom P; Carlsson J Int J Oncol; 2000 Sep; 17(3):559-64. PubMed ID: 10938398 [TBL] [Abstract][Full Text] [Related]
12. A variant epidermal growth factor receptor exhibits altered type alpha transforming growth factor binding and transmembrane signaling. Moriai T; Kobrin MS; Hope C; Speck L; Korc M Proc Natl Acad Sci U S A; 1994 Oct; 91(21):10217-21. PubMed ID: 7937865 [TBL] [Abstract][Full Text] [Related]
13. Internalisation and retention of EGF-dextran associated radioactivity in transfected Chinese hamster ovary cells expressing the human EGF-receptor. Olsson P; Collins VP; Liu L; Gedda L; Liljegren A; Carlsson J Int J Oncol; 2002 May; 20(5):1057-63. PubMed ID: 11956604 [TBL] [Abstract][Full Text] [Related]
14. Conjugate chemistry, iodination and cellular binding of mEGF-dextran-tyrosine: preclinical tests in preparation for clinical trials. Zhao Q; Blomquist E; Bolander H; Gedda L; Hartvig P; Janson J; Lundqvist H; Mellstedt H; Nilsson S; Nistèr M; Sundin A; Tolmachev V; Westlin J; Carlsson J Int J Mol Med; 1998 Apr; 1(4):693-702. PubMed ID: 9852284 [TBL] [Abstract][Full Text] [Related]
15. Establishment and characterization of a new hamster pancreatic cancer cell line: the biological activity and the binding characteristics of EGF or TGF-alpha. Morita Y; Moriai T; Takiyama Y; Makino I Int J Pancreatol; 1998 Feb; 23(1):41-50. PubMed ID: 9520090 [TBL] [Abstract][Full Text] [Related]
16. Attenuated processing of epidermal growth factor in the face of marked degradation of transforming growth factor-alpha. Korc M; Finman JE J Biol Chem; 1989 Sep; 264(25):14990-9. PubMed ID: 2788651 [TBL] [Abstract][Full Text] [Related]
17. TM-1 cells from an established human malignant glioma cell line produce PDGF, TGF-alpha, and TGF-beta which cooperatively play a stimulatory role for an autocrine growth promotion. Kurimoto M; Endo S; Arai K; Horie Y; Nogami K; Takaku A J Neurooncol; 1994; 22(1):33-44. PubMed ID: 7714549 [TBL] [Abstract][Full Text] [Related]
18. Effects of dextranation on the uptake of peptides in micrometastases: studies on binding of EGF in tumor spheroids. Nilsson P; Gedda L; Sjöström A; Carlsson J Tumour Biol; 2001; 22(4):229-38. PubMed ID: 11399948 [TBL] [Abstract][Full Text] [Related]
19. Anti-EGFR monoclonal antibodies which act as EGF, TGF alpha, HB-EGF and BTC antagonists block the binding of epiregulin to EGFR-expressing tumours. Modjtahedi H; Komurasaki T; Toyoda H; Dean C Int J Cancer; 1998 Jan; 75(2):310-6. PubMed ID: 9462724 [TBL] [Abstract][Full Text] [Related]
20. [Growth factors produced by rat glioma cells: activities of transforming growth factors]. Kanno H; Shinonaga M; Kuwabara T; Umeda M No To Shinkei; 1989 Sep; 41(9):905-9. PubMed ID: 2590559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]